National Science Foundation Award Helps SHINE Accelerate Efforts to Become a Major Domestic Producer of Iodine-131
Monona, WI – SHINE Medical Technologies, a Wisconsin-based medical isotope company, announced today that it has been awarded $150,000 from the National Science Foundation for Phase I of an SBIR (Small Business Innovation Research) Grant.
U.S.-based Rayton Solar Inc is en route to revolutionize the world – by making solar energy cheaper than energy produced by fossil fuels. To date they have raised over one million dollars in seed funding.
Phoenix Nuclear Labs is the exclusive supplier of the particle accelerator or, “laser beam.”
Argonne National Laboratory Demonstration of SHINE Process Produces Commercial-Grade Medical Isotopes
Argonne National Laboratory (Argonne) and SHINE Medical Technologies, Inc. announced today that Argonne successfully demonstrated the production, separation and purification of molybdenum-99 (Mo-99) from SHINE’s innovative liquid target.
The resulting Mo-99 product purity was equivalent to the Mo-99 used in the supply chain today. The demonstration—known as Mini-SHINE—uses the same process flows that will be used in the SHINE manufacturing facility and further validates SHINE’s technical approach.
See also: Argonne – Mo-99 Press Release FINAL